Does Rallies show LXEO 10-K and 10-Q filings?

Rallies organizes LXEO SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.

Is LXEO research on Rallies investment advice?

No. Rallies provides research, data, and educational context for LXEO. It does not provide personalized investment advice.

LXEO (Lexeo Therapeutics, Inc. Common Stock) Stock Analysis - SEC Filings

Lexeo Therapeutics, Inc. Common Stock (LXEO) is a publicly traded Healthcare sector company. As of May 21, 2026, LXEO trades at $5.34 with a market cap of $369.84M and a P/E ratio of -2.67. LXEO moved +14.51% today. Year to date, LXEO is -45.76%; over the trailing twelve months it is +45.04%. Its 52-week range spans $1.45 to $11.72. Analyst consensus is strong buy with an average price target of $18.60. Rallies surfaces LXEO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find LXEO SEC filings?

Rallies organizes LXEO SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

LXEO Key Metrics

Key financial metrics for LXEO
Metric	Value
Price	$5.34
Market Cap	$369.84M
P/E Ratio	-2.67
EPS	$-1.86
Dividend Yield	0.00%
52-Week High	$11.72
52-Week Low	$1.45
Volume	14
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-99.96M
Gross Margin	0.00%

Latest LXEO News

Lexeo Unveils Porcine TNNI3 Model and 10L-200L AAV Scale-Up at ASGCT — Apr 27, 2026
Lexeo’s LX2006 Shows LVMI, Troponin Declines; LX2020 Cuts VT by 60% — Feb 28, 2026
Lexeo Details 30% LV Mass Reduction, FDA OKs Pooled Phase I/II for LX2006 — Feb 14, 2026

Recent LXEO Insider Trades

Townsend Richard Nolan sold 55.00K (~$313.14K) on Apr 6, 2026.
Otero Jose Manuel sold 3.02K (~$19.29K) on Feb 18, 2026.
Townsend Richard Nolan sold 10.17K (~$64.92K) on Feb 18, 2026.

LXEO Analyst Consensus

5 analysts cover LXEO: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $18.60.

Common questions about LXEO

Where can I find LXEO SEC filings?: Rallies organizes LXEO SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show LXEO 10-K and 10-Q filings?: Rallies organizes LXEO SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is LXEO research on Rallies investment advice?: No. Rallies provides research, data, and educational context for LXEO. It does not provide personalized investment advice.